ARNOLD & PORTER KAYE SCHOLER LLP

Lobbying for REGENERON PHARMACEUTICALS, INC. · Biopharmaceutical development and manufacturing

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · New York · Senate · posted Apr 20, 2026

Lobbying activity 2

Budget/Appropriations

Outreach related to FY 2027 appropriations.

Health Issues

Outreach related to FY 2027 appropriations.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.